Kry is a company.
Kry has raised $736.0M across 6 funding rounds.
Key people at Kry.
Kry was founded by Fredrik Jung Abbou (Co-founder/Special Projects).
Kry has raised $736.0M in total across 6 funding rounds.
Kry was founded by Fredrik Jung Abbou (Co-founder/Special Projects).
Kry has raised $736.0M in total across 6 funding rounds.
Kry's investors include Alven, Bain Capital Ventures, Bond, Global Founders Capital, Index Ventures, Project A Ventures, Stefan Blom.
Key people at Kry.
# High-Level Overview
Kry is Europe's leading digital healthcare provider that combines proprietary technology with clinical expertise to deliver accessible, efficient primary and urgent care[1]. Founded in 2015, the company has delivered over 200 million patient interactions, enabling patients to consult with doctors, nurses, and psychologists online within minutes[1]. Kry serves patients across multiple European markets by integrating digital consultations with physical clinics, addressing the growing demand for convenient healthcare while reducing administrative burden on medical professionals through AI-powered tools[3].
The company solves a critical healthcare access problem: long wait times, geographic barriers, and fragmented care systems that prevent timely treatment. Kry's growth momentum is substantial—the platform experienced a 200%+ increase in consultations since 2020 and now serves over 100 million patients across Europe[2]. Beyond patient-facing services, Kry has expanded into B2B offerings through Kry Pro, a SaaS platform for healthcare professionals that streamlines administrative tasks and improves care coordination[2].
# Origin Story
Kry was founded in 2015 by Johannes Schildt with the mission to make healthcare more accessible and convenient[4]. The company initially launched as Livi before establishing its Kry brand, which means "healthy and well" in Swedish—reflecting the company's proactive health philosophy[7]. Early traction came rapidly: by 2020, Kry merged with Helsa, one of Sweden's largest healthcare companies, significantly expanding its clinical network and patient reach[7]. This strategic acquisition marked a pivotal moment, enabling Kry to transition from a pure telemedicine player to an integrated digital-physical healthcare ecosystem[4].
The company demonstrated operational agility during the COVID-19 pandemic, delivering over 400,000 vaccination and testing appointments across Sweden and becoming one of the country's largest contributors to its vaccination program[2]. This crisis period validated Kry's model and accelerated adoption of digital healthcare across its markets.
# Core Differentiators
# Role in the Broader Tech Landscape
Kry exemplifies the convergence of three powerful trends: digital-first healthcare delivery, AI-driven operational efficiency, and platform-based ecosystem thinking. The company rides the post-pandemic acceleration of telemedicine adoption while addressing healthcare systems' structural inefficiencies—long wait times, administrative overhead, and fragmented care pathways[1][3].
The timing is critical: European healthcare systems face mounting pressure from aging populations, chronic disease prevalence, and resource constraints. Kry's model demonstrates that technology can simultaneously improve access, reduce costs, and enhance quality—a rare alignment in healthcare[3]. By partnering across public and private sectors rather than competing against traditional providers, Kry influences the broader ecosystem toward integrated, technology-enabled care delivery[4].
The company's adoption of generative AI signals a shift in healthcare technology from connectivity tools to intelligence platforms that can extract insights from clinical data at scale, potentially reshaping how care is coordinated and personalized[3].
# Quick Take & Future Outlook
Kry is positioned at the intersection of healthcare's digital transformation and AI revolution. The company's next frontier likely involves deepening its specialist services (already launching in France across gynecology, pediatrics, dermatology, and other specialties)[2], expanding its Kry Pro SaaS offering to healthcare systems beyond its direct patient base, and leveraging AI to move from reactive treatment to proactive, personalized medicine[3].
The key question shaping Kry's evolution: can it scale its integrated model—combining digital, physical, and AI-driven care—across fragmented European healthcare systems without losing operational efficiency? Success would position Kry not merely as a telemedicine provider but as a fundamental reimagining of how modern healthcare systems operate. The company's ability to navigate regulatory complexity while maintaining clinical quality suggests it has the organizational maturity to achieve this ambition.
Kry has raised $736.0M across 6 funding rounds. Most recently, it raised $160.0M Series D in July 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2022 | $160.0M Series D | Alven, Bain Capital Ventures, Bond, Global Founders Capital, Index Ventures, Project A Ventures, Stefan Blom | |
| Apr 1, 2021 | $320.0M Series D | Alven, Bain Capital Ventures, Bond, Global Founders Capital, Index Ventures, Project A Ventures, Stefan Blom | |
| Jan 1, 2020 | $160.0M Series C | Alven, Bain Capital Ventures, Bond, Global Founders Capital, Index Ventures | |
| Jun 1, 2018 | $66.0M Series B | Alven, Bain Capital Ventures, Bond, Global Founders Capital, Index Ventures, Project A Ventures, Stefan Blom | |
| Jun 1, 2017 | $23.0M Series A | Alven, Bain Capital Ventures, Bond, Global Founders Capital, Index Ventures, Project A Ventures, Stefan Blom | |
| Aug 1, 2016 | $7.0M Seed | Alven, Bain Capital Ventures, Bond, Global Founders Capital, Index Ventures, Project A Ventures, Stefan Blom |
